EFGARTIGIMOD

Clinical trials for EFGARTIGIMOD explained in plain language.

Never miss a new study

Get alerted when new EFGARTIGIMOD trials appear

Sign up with your email to follow new studies for EFGARTIGIMOD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for safer surgery in rare Nerve-Muscle disorder

Disease control Not yet recruiting

This study aims to find the better treatment to help control muscle weakness in people with a specific type of myasthenia gravis who need surgery to remove a chest tumor called a thymoma. It will compare a newer drug, efgartigimod, against the standard treatment, intravenous immu…

Matched conditions: EFGARTIGIMOD

Phase: PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control

Last updated Mar 11, 2026 14:53 UTC

EFGARTIGIMOD

Get alerted when new EFGARTIGIMOD trials appear

New hope for safer surgery in rare Nerve-Muscle disorder